Merrill Lynch downgrades MKS Instruments (MKSI) to Neutral
- Market Wrap: Pending Home Sales Reach Multi-Year Highs; M&A Rules the Day; Tesla Plans New Product Launch
- OptumRx to Acquire Catamaran (CTRX) for $61.50/Share (UNH)
- After-Hours Stock Movers 03/30: (DRYS) (TSLA) (HLT) Higher; (EGY) (SNTA) (TCK) Lower (more...)
- AIG (AIG) Chairman Miller Will Step Down in July
- Tesla (TSLA) CEO Musk: Major New Product Line Being Unveiled April 30th
Merrill Lynch downgrades MKS Instruments (Nasdaq: MKSI) from Buy to Neutral
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Xilinx (XLNX) to Neutral
- Piper Jaffray Downgrades Auspex Pharmaceuticals (ASPX) to Neutral
- Roth Capital Downgrades Superior Drilling Products (SDPI) to Neutral
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!